Multiple Sclerosis

Multiple sclerosis (MS) is a severe autoimmune disease of the central nervous system that affects the brain and spinal cord, causing problems with muscle movement, balance and vision.

Multiple Sclerosis (MS)

Multiple sclerosis (MS) is a neurodegenerative disorder that damages the nerves in the brain and spinal cord, leading to problems with muscle movement, balance and vision.

Multiple Sclerosis Epidemiology

Multiple Sclerosis and Pregnancy

Optic Neuritis and Multiple Sclerosis

Primary Progressive Multiple Sclerosis (PPMS)

Early Signs of Multiple Sclerosis

How is RRMS Different from PPMS and SPMS?

Relapsing-Remitting Multiple Sclerosis (RRMS)

Types of Multiple Sclerosis (MS)

See more featured articles »

Benign Multiple Sclerosis (MS)

At-Home Physiotherapy Exercises for Multiple Sclerosis

Remyelination Strategies for Multiple Sclerosis

Epigenetics for Multiple Sclerosis

Multiple Sclerosis in Children

What Causes Multiple Sclerosis?

Heat Intolerance in Multiple Sclerosis

Anti-Myelin Antibodies in Multiple Sclerosis

Multiple Sclerosis and Women’s Health

Secondary Progressive Multiple Sclerosis (SPMS)

Multiple sclerosis and smoking

Cognitive Impairment and Multiple Sclerosis

Multiple sclerosis and beta interferon

Working Towards Earlier Diagnosis of Multiple Sclerosis

Latest Multiple Sclerosis News and Research

Early B-cell therapy linked to better MS disease control

For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after two years, based on the first treatment they used, according to a study published September 9, 2026, in Neurology Open Access, an official journal of the American Academy of Neurology.

9 Sep 2026

Astrocyte changes may explain how stress affects mental health

A new study led by UCLA Health researchers has identified a specific type of brain cell and a tiny structure on its surface that changes when the body is under stress, which may help explain why stress can lead to anxiety and depression.

8 Sep 2026

Atherosclerosis qualifies as an autoimmune disease

A new study in mice and patients shows that atherosclerosis meets the criteria for an autoimmune disease.

7 Sep 2026

More Americans with disabilities found work despite broader employment decline

More Americans with disabilities were working in August, tying the record high reached in November 2025, even as employment among people without disabilities declined, according to today's National Trends in Disability Employment–Jobs Report (nTIDE), issued by Kessler Foundation and the University of New Hampshire's Institute on Disability.

4 Sep 2026

Autoimmune diseases form distinct genetic clusters, study finds

Different autoimmune diseases often share genetic risk factors, but not through a single common genetic vulnerability.

4 Sep 2026

Immigrants face longer ICU stays after stroke in Canada

Among people who have a stroke in Canada, immigrants were admitted to the intensive care unit (ICU) at similar rates as long-term residents or people who were born in Canada, but they were more likely to have longer stays in the ICU, according to a study published September 2, 2026, in Neurology, the medical journal of the American Academy of Neurology.

2 Sep 2026

Shared biological pathways may explain chronic fatigue across diseases

A shared biological secret that helps explain chronic exhaustion in conditions including long Covid and PTSD has been discovered by researchers at the University of East Anglia and Oxford BioDynamics.

2 Sep 2026

MS patients' quality of life associated with walking performance and functional capacity

A study by the University of Eastern Finland found that quality of life in people with multiple sclerosis (MS) is strongly associated with their walking performance and functional capacity.

1 Sep 2026

AAN launches new resource to help people find reliable information about brain health

The American Academy of Neurology (AAN) has launched BrainHealth.com, a new public resource offering expert-reviewed information, tools and stories to help people improve and protect their brain health.

1 Sep 2026

Multiple sclerosis treatment approach developed at Mainz University moves toward clinical application

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.

1 Sep 2026

Targeted MS treatment protects the overall immune system

UZH researchers have developed a novel therapy for multiple sclerosis that is designed to stop the misguided immune response without suppressing the immune system as a whole.

1 Sep 2026

New guideline updates medications for preventing migraine in adults

To help clinicians determine which medications may be most effective at preventing migraine in adults, the American Academy of Neurology (AAN) and American Headache Society (AHS) have issued a joint practice guideline update with evidence-based recommendations, published on August 31, 2026, in Neurology®, the medical journal of the American Academy of Neurology, and in Headache, the official journal of the American Headache Society.

31 Aug 2026

Extreme heat exposure triggers broad range of medical emergencies

When temperatures spike, emergency physicians expect to see more cases of dehydration and heat stroke.

27 Aug 2026

Brain shrinkage biomarker may predict early-onset Alzheimer’s progression

In people diagnosed with early-onset Alzheimer's disease, a biomarker tool that detects shrinkage of the brain's gray matter may predict how quickly someone may progress from mild cognitive impairment (MCI) to dementia, according to a new study published August 26, 2026, in Neurology, an official journal of the American Academy of Neurology.

27 Aug 2026

Emergency diagnoses of medical conditions predict worse patient survival

Patients diagnosed with conditions after an emergency hospital admission or an emergency room visit face a higher risk of death than those diagnosed in non-emergency settings, according to a large population-based study by Emma Whitfield and colleagues from University College London, UK, published August 25th in the open access journal PLOS Medicine.

25 Aug 2026

Dysfunctional myelin-producing brain cells contribute to age-related cognitive decline

Brain cells that produce the protective coating around nerve fibers can become dysfunctional with age and may actively contribute to cognitive decline, according to new research.

25 Aug 2026

Brain organoid studies on the ISS move closer to new treatments

Research using human brain organoids onboard the International Space Station International Space Station (ISS) helped lead to the clinical trial of a potential therapy for Rett syndrome, a debilitating neurological disorder in children.

20 Aug 2026

Paternal valproate use not linked to offspring neurodevelopmental risks

Use of the antiseizure drug valproate by fathers before conception is not associated with neurodevelopmental disorders like autism or attention-deficit/hyperactivity disorder (ADHD) in their children, according to a new study published August 19, 2026, in Neurology®, an official journal of the American Academy of Neurology.

19 Aug 2026

Later-life estrogen therapy associated with lower risk of developing dementia

Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a study published August 12, 2026, in Neurology, the medical journal of the American Academy of Neurology.

12 Aug 2026

FDA clears first self-balancing personal exoskeleton for wheelchair users

The U.S. Food and Drug Administration has cleared Eve™, the first self-balancing personal exoskeleton for eligible wheelchair users living with spinal cord injury.

11 Aug 2026